HM-001 is under clinical development by HOIST and currently in Phase II for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer). According to GlobalData, Phase II drugs for Non ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback